Avita Medical Ltd
AVITA Medical, Inc., together with its subsidiaries, operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds and full-thickness skin defects, as well as for repigmentation of stable depigmented vitili… Read more
Avita Medical Ltd (RCEL) - Total Liabilities
Latest total liabilities as of December 2025: $73.04 Million USD
Based on the latest financial reports, Avita Medical Ltd (RCEL) has total liabilities worth $73.04 Million USD as of December 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Avita Medical Ltd - Total Liabilities Trend (1993–2025)
This chart illustrates how Avita Medical Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Avita Medical Ltd Competitors by Total Liabilities
The table below lists competitors of Avita Medical Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
OrganiGram Holdings Inc
NASDAQ:OGI
|
USA | $161.09 Million |
|
Open Orphan plc
PINK:OPORF
|
USA | $42.04 Million |
|
Vinte Viviendas Integrales S.A.B. de C.V
MX:VINTE
|
Mexico | MX$18.35 Billion |
|
Global Standard Technology Limited
KQ:083450
|
Korea | ₩70.22 Billion |
|
Hi-Lex Corporation
PINK:HLXFF
|
USA | $85.31 Billion |
|
ZYF Lopsking Aluminum Co Ltd
SHE:002333
|
China | CN¥1.25 Billion |
|
MYT Netherlands Parent BV
NYSE:MYTE
|
USA | $280.60 Million |
|
Troilus Gold Corp
OTCQX:CHXMF
|
USA | $32.94 Million |
Liability Composition Analysis (1993–2025)
This chart breaks down Avita Medical Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.57 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -4.39 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 1.30 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Avita Medical Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Avita Medical Ltd (1993–2025)
The table below shows the annual total liabilities of Avita Medical Ltd from 1993 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $73.04 Million | -2.89% |
| 2024-12-31 | $75.21 Million | +20.18% |
| 2023-12-31 | $62.58 Million | +362.76% |
| 2022-12-31 | $13.52 Million | +18.73% |
| 2021-12-31 | $11.39 Million | +13.22% |
| 2020-12-31 | $10.06 Million | +103.17% |
| 2019-12-31 | $4.95 Million | +23.34% |
| 2017-12-31 | $4.01 Million | +57.68% |
| 2016-12-31 | $2.55 Million | +45.46% |
| 2015-12-31 | $1.75 Million | +42.74% |
| 2014-12-31 | $1.23 Million | -31.35% |
| 2013-12-31 | $1.79 Million | -27.19% |
| 2012-12-31 | $2.45 Million | +14.00% |
| 2011-12-31 | $2.15 Million | +26.54% |
| 2010-12-31 | $1.70 Million | -56.17% |
| 2009-12-31 | $3.88 Million | +287.84% |
| 2008-12-31 | $1.00 Million | -60.72% |
| 2007-12-31 | $2.55 Million | +138.67% |
| 2006-12-31 | $1.07 Million | -44.69% |
| 2005-12-31 | $1.93 Million | +38.67% |
| 2004-12-31 | $1.39 Million | +172.15% |
| 2003-12-31 | $511.27K | +63.12% |
| 2002-12-31 | $313.44K | -40.36% |
| 2001-12-31 | $525.57K | +1351.65% |
| 2000-12-31 | $36.21K | -58.71% |
| 1999-12-31 | $87.69K | +342.35% |
| 1998-12-31 | $19.82K | +4.35% |
| 1997-12-31 | $19.00K | -61.80% |
| 1996-12-31 | $49.74K | -41.90% |
| 1995-12-31 | $85.60K | -64.52% |
| 1994-12-31 | $241.24K | -36.85% |
| 1993-12-31 | $381.99K | -- |